<?xml version="1.0" encoding="UTF-8"?>
<p id="p0370">Despite advances in prevention, immunotherapy and drug development, some infectious diseases still require effective vaccines or efficient antiviral therapies. As an example, coronaviruses, including SARS-CoV2 (
 <xref rid="bib99" ref-type="bibr">Zhou et al., 2020</xref>), that is causing the current pandemic disease, COVID19, as well as the other two epidemic coronaviruses, SARS (
 <xref rid="bib71" ref-type="bibr">Rota et al., 2003</xref>) and MERS (
 <xref rid="bib95" ref-type="bibr">Zaki et al., 2012</xref>), together with other coronaviruses, do not have suitable therapies or preventive treatments yet (
 <xref rid="bib74" ref-type="bibr">Sanders et al., 2020</xref>). Therefore, the identification of appropriate antiviral effectors for drugs and food design is of fundamental importance to fight the COVID19 disease and all its side effects, to be ready for possible future challenges that can be determined by coronaviruses attacks (
 <xref rid="bib56" ref-type="bibr">Osterholm, 2005</xref>).
</p>
